|
| | Fourth-generation accommodating IOL gets FDA ok
| | July 8, 2008 | The fourth-generation Crystalens HD (Bausch & Lomb) accommodating intraocular lens (IOL) has received FDA marketing approval, five years after the lens was initially launched on the market. |
| | | Postoperative pain steroid approved
| | June 30, 2008 | | Durezol (difluprednate ophthalmic emulsion; Sirion Therapeutics) 0.05%, a topical steroid, has received US Food and Drug Administration (FDA) approval for the treatment of postoperative ocular inflammation and pain. |
| | NSAID activity at trough drug levels
| | June 23, 2008 | | Animals undergoing lens removal surgery were treated with non-steroidal anti-inflammatory drugs pre- and postoperatively. On the first day after surgery, aqueous humor samples were taken at times corresponding to trough drug levels. The mean aqueous prostaglandin E2 concentration was significantly lower in animals being treated with ketorolac 0.4% (Acular LS, Allergan) compared with those receiving bromfenac 0.09% (Xibrom, ISTA Pharmaceuticals). |
|
|
|
| Study evaluates safety of intracameral moxifloxacin
| | June 30, 2008 | | The safety of intracameral moxifloxacin (Vigamox, Alcon Laboratories) for post cataract surgery endophthalmitis prophylaxis was investigated in a prospective, randomized, controlled study. Statistical analyses of multiple postoperative outcome measures demonstrated no significant differences between patients who received intracameral moxifloxacin and controls treated with intracameral balanced salt solution. |
| | | Arsenal of strategies enables safe surgery in IFIS eyes
| | April 21, 2008 | | Cases of intraoperative floppy iris syndrome (IFIS) encompass a wide spectrum of severity, so it is important for surgeons to master several different strategies to increase the likelihood of achieving a safe outcome in these eyes. |
| | We have microincisions & now we have a suitable IOL
| | April 1, 2008 | | I have been so impressed with the aspheric optics and good centration of the Akreos MI60 that I use it as my first choice for implantation; including in patients with visual-critical occupations such as aviators and air traffic controllers |
| | Microincision IOLs go head-to-head
| | April 1, 2008 | | Nowadays, cataract surgery not only has a therapeutic purpose, which is to substitute an opaque lens with a transparent IOL, but it also has a refractive aim; to correct previous refractive defects in order to eliminate the use of spectacles. The need for a good postoperative visual acuity and a fast functional recovery has lead cataract surgery to become more and more micro-invasive in nature so that surgical trauma is reduced, a faster recovery and good, time-stable visual results are achieved.1 The achievement of this goal has been realized, thanks to the improvement of surgical techniques, in the form of microcoaxial phacoemulsification and bimanual microphacoemulsification,2 which now allow the almost complete reduction of surgically induced astigmatism. |
|
|
| 
